• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[One point determination of oral caffeine clearance in patients with liver diseases].

作者信息

Richter E, Brachtel D, Hofstetter G, Joeres R, Klinker H, Junggeburth J, Epping J, Zilly W

机构信息

Med. Univ.-Klinik Würzburg.

出版信息

Z Gastroenterol. 1988 Dec;26(12):744-9.

PMID:3149826
Abstract

Caffeine clearance has been determined in 117 volunteers and patients (including 27 patients with liver cirrhosis) after oral application of 366.1 mg caffeine according to conventional pharmacokinetic methods (Cl = D/AUC). The resulting clearance values can be estimated with adequate accuracy from the plasma concentration at 12h for a concentration range of 2.0 to 6.5 mg/l according to Cl max = Doses/C 12h x t 12h x e and for concentrations higher than 6.5 mg/l according to Cl = Vd x (1n (D/Vd) - 1n C 12h/t 12h Vd is estimated from body weight as Vd = 0.42 x BW. "One - point" - estimation does not provide reliable data for plasma concentrations below 2.0 mg/l.

摘要

相似文献

1
[One point determination of oral caffeine clearance in patients with liver diseases].
Z Gastroenterol. 1988 Dec;26(12):744-9.
2
Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
Tokai J Exp Clin Med. 1996 Dec;21(4-6):195-201.
3
[Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].[肝硬化患者唾液中对黄嘌呤/咖啡因比值的应用]
Cas Lek Cesk. 2001 Feb 1;140(2):51-3.
4
Caffeine clearance in patients with chronic viral hepatitis: before and after interferon therapy.
J Med Assoc Thai. 2001 Jun;84 Suppl 1:S189-96.
5
Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
Z Gastroenterol. 1993 Feb;31 Suppl 2:56-61.
6
A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites.一种利用咖啡因及其三种主要二甲基代谢物测定肝硬化患者肝功能的简单实用方法。
Int J Clin Pharmacol Ther Toxicol. 1992 Sep;30(9):336-41.
7
Serum metabolite/caffeine ratios as a test for liver function.
J Clin Pharmacol. 2004 Apr;44(4):338-47. doi: 10.1177/0091270004263468.
8
Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.在两项针对健康志愿者的研究以及两项针对慢性肾病患者的研究中,δ-促红细胞生成素的药代动力学和药效学。
Clin Ther. 2007 Jul;29(7):1368-80. doi: 10.1016/j.clinthera.2007.07.014.
9
Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatment.经导管油化疗栓塞治疗后肝细胞癌患者的咖啡因清除率
J Med Assoc Thai. 2002 Dec;85(12):1280-7.
10
Estimation of indocyanine green elimination rate constant k and retention rate at 15 min using patient age, weight, bilirubin, and albumin.利用患者年龄、体重、胆红素和白蛋白估算吲哚菁绿消除率常数k及15分钟时的潴留率。
J Hepatobiliary Pancreat Surg. 2009;16(4):521-8. doi: 10.1007/s00534-009-0097-3. Epub 2009 Apr 14.